• Vol. 51 No. 4, 253–254
  • 28 April 2022

An initial experience with laser haemorrhoidoplasty in addition to mucopexy for symptomatic haemorrhoids


0 Citing Article

Download PDF

Dear Editor,

Symptomatic haemorrhoids is the most common anorectal disorder, where up to 75% of people experience symptoms sometime in their lives.1

The current gold standard for the surgical management of haemorrhoids is the Milligan-Morgan haemorrhoidectomy,2 with unrivalled long-term results.3 However, the technique is associated with significant postoperative pain,4,5 leading to delayed return to normal activities and readmissions.

Laser haemorrhoidoplasty (LHP) is an emerging procedure whereby haemorrhoidal arterial flow is ceased by laser coagulation.6 Small comparative studies have shown that LHP is associated with less postoperative pain when compared to conventional open haemorrhoidectomy (COH).7

The authors would like to describe our initial experience and evaluate the short-term effectiveness of LHP in Singapore. This initial assessment was conducted during the familiarisation period that preceded a single-centre randomised controlled trial (RCT) (NCT04329364) comparing LHP to COH. All patients presenting with symptomatic haemorrhoids were evaluated for suitability. Inclusion criteria included patients aged 21–90 years with symptomatic grade II–IV haemorrhoids; those willing to attend follow-up visits; and patients who were able to complete postoperative monitoring questionnaires. Exclusion criteria included patients on anticoagulation and those with previous surgical treatment (excluding rubber band ligations). Patients would undergo endoscopic evaluation to ascertain symptoms were attributed to haemorrhoids alone.

LHP is performed as an elective day surgery under general anaesthesia by colorectal surgeons. The procedure is performed with LEONARDO Laser Dual 45 (biolitec AG, Vienna, Austria) using a 1470nm diode laser wavelength. Mucopexy is done as an adjunct prior to laser treatment, to address the external or prolapsed component of the haemorrhoids. It is performed by placing a vicryl 2/0 stitch starting above the dentate line and progressing proximally to hitch haemorrhoidal tissue proximally; no tissue excised. The laser probe is then introduced by direct puncture into the haemorrhoidal cushion under direct vision to a level higher than the dentate line, aided by the guiding beam emitted from the laser probe. The laser treatment uses the “pulsed treatment mode” with power of 10–15W and pulse durations of 3 seconds each. After each laser firing, the haemorrhoidal pedicles are compressed with finger for 3 minutes, and iced in glove for 2 minutes. The probe is then withdrawn by 5mm, resulting in a cylindrical treatment area. After treatment, a lubricated Spongostan (Johnson & Johnson, US) is inserted to tamponade the operative area. Postoperatively, patients will be prescribed oral metronidazole, analgesia, stool softeners and Daflon.

Postoperative pain was recorded using a visual analogue scale (VAS), where 0 represents no pain and 10, the worst pain imaginable. VAS scores were collected every day from postoperative day (POD) 0 to POD10.

Quality-of-life (QoL) assessment was performed using 2 validated surveys to evaluate the effectiveness of LHP, by comparing patient’s preoperative and postoperative symptoms. Nyström’s questionnaire8 and Chew’s questionnaire9 focused on frequency and severity of haemorrhoid-related symptoms, respectively. They were performed on patients preoperatively, POD7 and 3 months postoperatively (POD 3 months).

A total of 13 patients aged 41–72 years were recruited for this study. Majority of the patients had grade III–IV haemorrhoids (n=11, 84.6%). The 2 most common symptoms that patients experienced were bleeding (n=8, 61.5%) and prolapse (n=7, 53.8%). The median operating time was 60 (range 44–101) minutes. The median laser therapy duration was 78 (range 28–180) seconds, not including insertion of laser probe and checking of its positioning. The median energy used was 761J (range 262–1,192.6J).

Overall, there was significant improvement of symptoms in both QoL assessments. Seven of the patients (53.8%) noted complete resolution of preoperative symptoms by POD7, and 100% of patients noted complete (n=12, 92.3%) or partial resolution (n=1, 7.7%) of symptoms by POD 3 months. Nine patients (69.2%) complained of bleeding from the haemorrhoids preoperation. By POD7, only 3 of these patients (23.1%) had residual per-rectal bleeding. At POD 3 months, none of the patients were experiencing per-rectal bleeding. Six patients (46.2%) complained of daily occurrence of prolapse preoperatively. By POD 3 months, none of the patients had prolapse.

Overall, there was a downward trend in the mean score for postoperative pain (Fig. 1). The mean score for POD0 was 2.6, and gradually decreased towards POD10, where the mean score was 0.8. The results showed that most patients had little to no pain by POD7 (mean score 0.8). From POD0–POD5, the maximum pain score of 6 can be explained by a patient who experienced pain from a thrombosed haemorrhoid post-LHP, requiring analgesic adjustment without further intervention. Subsequent review at 3-months showed resolution of the thrombosis.

Fig. 1. Postoperative pain using visual analogue scale.

There were no intraoperative adverse events. Postoperative complications that required re-admission occurred in 2 patients (15.4%). The first had acute urinary retention secondary to severe benign prostate hyperplasia and was managed by urology. The other was for thrombosis of remnant haemorrhoidal tissue requiring analgesia adjustment as mentioned before.

The results from our initial experience show that LHP is effective in addressing symptoms faced by patients with haemorrhoids. It is also a safe procedure with minimal postoperative complications. There was no return to the operating theatre and no sphincter injury noted from this pool of patients. Postoperative pain was minimal (low mean VAS score) and resolved within 1 week postoperation. While not a direct comparison, this initial experience potentially shows that LHP has less postoperative pain. In contrast, COH usually causes significant postoperative pain because of wide external perianal wounds, with pain lasting up to 2 weeks.4,5

Preliminary studies have shown significantly better postoperative pain scores and less bleeding risk7,10 in LHP. However, none has addressed the QoL and longer-term outcomes of LHP in comparison to COH.

Limitations in our study include the small number of reviewed cases, hence may not be representative of the population. There is no control group thus the inability to do direct comparison to confirm the suggested benefits in terms of efficacy as well as less postoperative pain.

LHP is a relatively new technique in Singapore; thus, surgeons are still mounting the learning curve during this study. Despite that, the early outcomes of LHP are already favourable, with its promise of being a new approach towards treating haemorrhoids. The initial study shows that LHP has the potential to be as effective as COH, without the latter’s inconvenience. The Colorectal Department of Sengkang General Hospital, Singapore is currently doing a RCT (NCT04329364) to compare LHP and COH, with follow-up of up to a year. We look forward to seeing favourable short- and long-term results from the trial.


  1. Cocchiara JL. Hemorrhoids. A practical approach to an aggravating
    problem. Postgrad Med 1991;89:149-52.
    2. Davis BR, Lee-Kong SA, Migaly J, et al. The American Society of
    Colon and Rectal Surgeons Clinical Practice Guidelines for the
    management of hemorrhoids. Dis Colon Rectum 2018;61:284-92.
    3. Giordano P, Gravante G, Sorge R, et al. Long-term outcomes of
    stapled hemorrhoidopexy vs conventional hemorrhoidectomy:
    a meta-analysis of randomized controlled trials. Arch Surg 2009;
    4. Watts JM, Bennett RC, Duthie HL, et al. Pain after haemorrhoidectomy.
    Surg Gynecol Obstet 1965;120:1037-42.
    5. Gabrielli F, Chiarelli M, Guttadauro A, et al. The problem of pain
    after day-surgery haemorrhoidectomy. Ambul Surg 1998;6:29-34.
    6. Faes S, Pratsinis M, Hasler-Gehrer S, et al. Short- and long-term
    outcomes of laser haemorrhoidoplasty for grade II-III haemorrhoidal
    disease. Colorectal Dis 2019;21:689-96.
    7. Maloku H, Gashi Z, Lazovic R, et al. Laser Hemorrhoidoplasty
    Procedure vs Open Surgical Hemorrhoidectomy: a Trial Comparing
    2 Treatments for Hemorrhoids of Third and Fourth Degree. Acta
    Inform Med 2014;22:365-7.
    8. Nyström PO, Qvist N, Raahave D, et al. Randomized clinical trial
    of symptom control after stapled anopexy or diathermy excision
    for haemorrhoid prolapse. Br J Surg 2010;97:167-76.
    9. Chew MH, Kam MH, Lim JF, et al. The evaluation of CEEA 34
    for stapled hemorrhoidectomy: results of a prospective clinical trial
    and patient satisfaction. Am J Surg 2009;197:695-701.
    10. Crea N, Pata G, Lippa M, et al. Hemorrhoidal laser procedure: shortand
    long-term results from a prospective study. Am J Surg 2014;